Insights
Little Green Pharma (ASX:LGP) receives manufacturing permit
We have been granted a new manufacturing permit from the Office of Drug Control. Read more...
May 2020
Export licence approved
Company news
01 Jan 2019
Little Green Pharma is pleased to announce the company has been granted an Export Licence by the Federal Department of Health, effective 15 January 2019. Obtaining this license meets one of Little Green Pharma’s key strategic milestones on the path to become a key domestic and international supplier of medical cannabis products.
Managing Director, Fleta Solomon believes the strict growing and manufacturing conditions applicable to local suppliers will ultimately give Australian medical cannabis the edge over international competitors, many of which are subject to less stringent quality and manufacturing standards.
Little Green Pharma’s goal is to make clean and natural, Australian-grown and medical grade medical cannabis products to supply both the Australian and overseas markets in 2019.
You might also be interested in
Insights
Little Green Pharma Stands Out Amid The Crowded Cannabis Canopy
Little Green Pharma (ASX:LGP) has some genuine pioneering notches on its belt. Read the article here
May 2020
Company news
Another successful harvest
Little Green Pharma successfully harvest another medical cannabis crop and pass TGO 93.
Jun 2019